QualityStocks'  Instablog

Send Message
QualityStocks (www.qualitystocks.net) assists publicly traded companies by getting their story out to the investment community while helping investors discover emerging companies with plenty of growth potential. Our name, QualityStocks, emphasizes our commitment to connect subscribers with... More
My company:
My blog:
QualityStocks Micro-Cap and Small-Cap Blog
  • Boston Therapeutics, Inc. (BTHE) To Present At Livingston Securities Advanced And Nano Life Sciences Summit 0 comments
    Oct 16, 2013 10:44 AM | about stocks: BTHE

    Boston Therapeutics today announces it will be making a presentation on a corporate update at the Livingston Securities Advanced and Nano Life Sciences Summit. The presentation is to be given by the President of Boston Therapeutics, Kenneth A. Tassey, Jr., on October 17, 2013, in New York City.

    Mr. Tassey, Jr. will cover Boston Therapeutics' product pipeline, including PAZ320. Other topics of discussion to be covered during the presentation include the company's product to reduce post-meal glucose elevation as well as other corporate developments. The presentation will be available on Boston Therapeutics' website: ir.stockpr.com/bostonti/overview.

    Headquartered in Manchester, NH, Boston Therapeutics develops drugs that address diabetes using complex carbohydrate chemistry. Specifically the company is focused on development and commercialization of therapeutic molecules that address Type 2 diabetes. The company's initial product pipeline consists of:

    •PAZ320, a non-systemic, non-toxic, chewable drug candidate for prevention of diabetes and its complications. PAZ320 inhibits the enzymes that release glucose from complex carbohydrates in foods during digestion, reducing the amount of available glucose absorbed through the intestine.

    •IPOXYN™, a glyco-protein based therapeutic agent using proprietary processes and patented technology. IPOXYN™ is an anti-necrosis drug that consists of a stabilized glycoprotein composition containing oxygen-rechargeable iron, targeting both human and animal tissues and organ systems deprived of oxygen and in need of metabolic support.

    •OXYFEX™, a product that can serve as the only available oxygen delivery mechanism for animals suffering ischemia or traumatic and surgical blood loss events.

    The company is backed by a highly experienced and insightful management and scientific advisory team that has extensive expertise in complex carbohydrate chemistry, regulatory, and clinical development, with multiple submissions and approvals to U.S. Food and Drug Administration. Its executive management team has more than 100 years of combined experience.

    For more information, visit bostonti.com

    QualityStocks provides investor relations services to publicly traded companies in exchange for compensation. This article may be part of our efforts to widen a client's exposure. To read our full disclaimer, visit disclaimer.qualitystocks.net

    Stocks: BTHE
Back To QualityStocks' Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers


More »
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.